Gabriel Griffin, MD

Our lab works on finding new and better immunotherapies for cancer. To do this, we try to understand how cancer cells hide from the immune system. We also try to understand which proteins could be targeted with a drug to help the immune system find and kill cancer cells more effectively.

To accomplish this, we are studying ancient viruses that live in the DNA of all human cells. Usually, these viruses are kept quiet by “epigenetic repressors”. Our lab is studying how to turn on these viruses in cancer cells, with the goal of activating the immune system to kill the tumor.

We envision this approach leading to a new type of cancer therapy, which could be used in patients that don’t respond to standard immunotherapies.

Location: Dana-Farber/Harvard Cancer Center - Boston
Proposal: Harnessing Endogenous Retroviruses to Overcome Immunotherapy Resistance in Microsatellite-Stable Colorectal Cancer
Mailing List Mailing List
Close Mailing List